Website
https://www.cataliocapital.com
Sector
Financial and insurance activities
Industry
6630 Fund management

Search trends
Patents
KANDO id: 14394494

Corporate information

Company type

Multi-strategy investment firm focused on breakthrough biomedical technology companies worldwide.

Funding rounds

Investment preferences

Strategy:

Private equity

Investment criteria
Focus on biomedical technology companies developing next-generation drugs, devices and diagnostics, data, tools, and healthcare services and work closely with each portfolio company to build and grow the business from inception to exit.
Stage focus
Series A
Top investment portfolio themes
neuroscience (1)  

Actual initial investment stage
N/A (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Funding
Orpheris Inc Clinical-stage neuroscience company leveraging a platform technology that enabling selective delivery of therapeutic agents across the blood barrier.
United States
 N/A Initial investment Exited

Current team

Past employees

Selected Products / Customers

Financials